dexmedetomidine has been researched along with Abdominal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelemam, RM; Elmasry, HM; Fares, KM; Kamal, SM; Mansour, S; Mohamed, SA | 1 |
| El-Rahman, AM; Fares, KM; Mohamed, SA | 1 |
2 trial(s) available for dexmedetomidine and Abdominal Neoplasms
| Article | Year |
|---|---|
Immunosuppressive Effect of Intrathecal Morphine, Dexmedetomidine, or Both in Combination with Bupivacaine on Patients Undergoing Major Abdominal Cancer Surgery.
Topics: Abdominal Neoplasms; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Dexmedetomidine; Double-Blind Method; Humans; Interleukin-10; Interleukin-6; Morphine; Pain, Postoperative; Prospective Studies; Tumor Necrosis Factor-alpha | 2022 |
Intrathecal Dexmedetomidine, Ketamine, and their Combination Added to Bupivacaine for Postoperative Analgesia in Major Abdominal Cancer Surgery.
Topics: Abdominal Neoplasms; Adult; Analgesia; Anesthetics, Local; Bupivacaine; Dexmedetomidine; Double-Blind Method; Female; Humans; Ketamine; Male; Middle Aged; Morphine; Pain, Postoperative | 2016 |